These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25239180)

  • 1. Totally subcutaneous implantable cardioverter-defibrillator in a child with complex congenital heart disease and infection in a previous transvenous system.
    García-Riesco L; Pedrote A; Arana-Rueda E; Adsuar A; Arce-León Á; Guerrero-Márquez F
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):961-2. PubMed ID: 25239180
    [No Abstract]   [Full Text] [Related]  

  • 2. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease.
    Waller JR; Salmon AP; Roberts PR
    Europace; 2015 Jan; 17(1):77. PubMed ID: 25414482
    [No Abstract]   [Full Text] [Related]  

  • 3. New transvenous implantable cardioverter defibrillator configuration for use after tricuspid valve surgery.
    Lopez JA
    Europace; 2008 Jun; 10(6):736-7. PubMed ID: 18424456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A completely subcutaneous implantable cardioverter defibrillator in a patient with situs inversus totalis.
    van Opstal JM; Blaauw Y; Pison LP
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):333. PubMed ID: 21539637
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of a fully subcutaneous ICD in children.
    McLeod KA; McLean A
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):e20-3. PubMed ID: 20723088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcutaneous defibrillator will replace the transvenous defibrillator.
    Crozier I
    J Interv Card Electrophysiol; 2011 Oct; 32(1):73-7. PubMed ID: 21523472
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.
    Lopez JA
    Europace; 2012 Jun; 14(6):853-8. PubMed ID: 22333241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.
    Nery PB; Green MS; Khairy P; Alhebaishi Y; Hendry P; Birnie DH
    Can J Cardiol; 2013 Feb; 29(2):254.e1-3. PubMed ID: 22749646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous implantable cardioverter defibrillator in a patient with pectus excavatum.
    Hamoud A; Barry J
    Pacing Clin Electrophysiol; 2013 May; 36(5):e138-9. PubMed ID: 22554273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent common arterial trunk with hexaleaflet truncal valve and intact ventricular septum.
    Sandoval Boburg R; Hahn JK; Hofbeck M; Schlensak C
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):915-916. PubMed ID: 33164055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.
    Russo AM; Chung MK
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423
    [No Abstract]   [Full Text] [Related]  

  • 14. Who should receive the subcutaneous implanted defibrillator?: Timing is not right to replace the transvenous implantable cardioverter defibrillator.
    Rav Acha M; Milan D
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1246-51; discussion 1251. PubMed ID: 24347600
    [No Abstract]   [Full Text] [Related]  

  • 15. The totally subcutaneous implantable defibrillator.
    Rhyner J; Knight BP
    Cardiol Clin; 2014 May; 32(2):225-37. PubMed ID: 24793799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems].
    Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K
    Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of a subcutaneous implantable cardioverter-defibrillator in a patient with pectus excavatum.
    Osca J; Cano Ó; Izquierdo MT; Saurí A; Sancho-Tello MJ; Martínez-Dolz L
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):92-94. PubMed ID: 31387797
    [No Abstract]   [Full Text] [Related]  

  • 18. A patient with congenital heart disease and ventricular tachycardia: what is the course of the device lead?
    Kanter RJ; Darden WB; Herlong JR; Barker PC; Jaggers J
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1401-3. PubMed ID: 17976107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of an infected Hancock prosthesis after repair of truncus arteriosus.
    Moseley PW; Ochsner JL; Mills NL; Chapman J
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):306-8. PubMed ID: 834069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.